Business ❯ Finance ❯ Corporate Governance ❯ Regulatory Compliance

Securities and Exchange Commission

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety and Launch Claims

Investors have until May 5, 2026 to seek lead‑plaintiff status in the Northern District of California case.

ADM Pays $40 Million to Settle SEC Case on Nutrition Accounting as DOJ Closes Probe

SEC Opens Civil Probe Into Jefferies Over First Brands Exposure

SEC Curtails 14a-8 No-Action Reviews for 2025–26 Proxy Season, Except State-Law Cases

Trump Renews Push to Replace Quarterly Reports With Semiannual Disclosures